OpenLobby.EU
Explore

European Association of E-Pharmacies

EAEP

The European Association of E-Pharmacies represents the interests of online pharmacies in Europe, advocating for digital health and medicine accessibility.

Lobbying Activity

Meeting with Marta Temido (Member of the European Parliament)

29 Jan 2026 · E-Pharmacies

Meeting with Sirpa Pietikäinen (Member of the European Parliament)

28 Jan 2026 · E-pharmacies

Meeting with Olivier Chastel (Member of the European Parliament)

28 Jan 2026 · Politique de santé de l'UE

E-pharmacy group urges channel-neutral healthcare in digital review

16 Dec 2025
Topic — The Commission is reviewing targets for Europe's digital transformation by 2030.
Message — The EAEP calls for a channel-neutral infrastructure where online pharmacies have full access to electronic health records and identity wallets. They request updated definitions to include e-prescriptions and e-dispensing services within the programme's scope.12
Why — This would remove discriminatory national barriers, allowing e-pharmacies to operate more freely across the single market.34
Impact — Physical pharmacies in certain countries would lose their protected exclusive status as online competition increases.5
Read full response

Meeting with Adam Jarubas (Member of the European Parliament, Committee chair)

14 Nov 2025 · Pharma Package

Meeting with Francesco Torselli (Member of the European Parliament, Shadow rapporteur)

15 Oct 2025 · Incontro conoscitivo

Response to Critical Medicines Act

26 Feb 2025

As the organisation representing the voice of the online pharmacy sector in Europe, the European Association of E-Pharmacies (EAEP) is particularly concerned with the growing issue of medicine shortages in Europe. This phenomenon stems from manufacturing issues, supply chain disruptions, and market dynamics, putting increasing pressure on healthcare systems. While online pharmacies play a crucial role in bridging supply gaps, they are also impacted by these shortages, which are more and more pressing for the sector and for patients accessing healthcare digitally. In the attached position paper, the EAEP recommends collaborative efforts between policymakers, pharmaceutical companies, and healthcare providers to address crucial vulnerabilities that affect the supply chain. On top of this, breaking the barriers to cross border digital access to medicines could grant patients access to the medicines they need and prevent the further development of shortages of both common and crucial medicines across Europe. Key recommendations include: 1) The swift adoption of the revised EU Pharmaceutical Legislation, including measures aimed at fostering the availability, affordability and accessibility of medicines. 2) Timely reporting by manufacturers, to detect and prevent unexpected shortages. 3) Facilitating the cross-border sale of medicines, by ensuring the interoperability of e-prescriptions and promoting simplified regulations on imports and compounding regulations. 4) Fostering transparency, communication and cooperation among all actors involved in the supply chain in observing market trends, to promptly and effectively address shortages. The EAEP emphasises the need for a strategic, coordinated approach to improve the security of the medicine supply in Europe. The Critical Medicines Act represents a unique opportunity to rethink the supply chain in a way that includes innovative solutions to the issue of shortages in the pharmaceutical supply chain. Please find attached the EAEPs full position paper on medicine shortages.
Read full response

European Association of E-Pharmacies urges harmonised digital health rules

30 Jan 2025
Topic — The Commission is consulting on the future of the EU Single Market Strategy.
Message — The group urges the EU to allow all citizens to buy prescription medicines online from authorized pharmacies. They call for the removal of national rules that block cross-border digital health services.12
Why — Standardized rules would enable these digital businesses to expand into nineteen currently closed markets.3
Impact — Local pharmacies may struggle as digital competitors enter markets with higher price transparency.4
Read full response

Meeting with Ondřej Dostál (Member of the European Parliament) and The European Organisation for Packaging and the Environment

26 Sept 2024 · Introduction

Response to Rules specifying the obligations laid down in Articles 21(5) and 23(11) of the NIS 2 Directive

24 Jul 2024

The European Association of E-Pharmacies (EAEP), which represents the online pharmacy sector in Europe and its patients, welcomes the opportunity to provide its feedback on the Draft Implementing Regulation as regards technical and methodological requirements of cybersecurity risk-management measures and further specification of the cases in which an incident is considered to be significant. Please find attached the EAEP's detailed feedback.
Read full response

Response to Report on the application of the General Data Protection Regulation

8 Feb 2024

The European Association of E-Pharmacies (EAEP), which represents online pharmacies and their patients on the European continent, welcomes the opportunity to provide its feedback on the implementation of the General Data Protection Regulation (GDPR), six years after its implementation. The EAEP feedback is attached.
Read full response

Meeting with Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides) and The Alliance for Safe Online Pharmacy in the EU

21 Nov 2023 · Exchange of views with the Alliance for Safe Online Pharmacy and the European Association of e-Pharmacies on the access to medicines in the context of the pharma reform.

Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur)

20 Oct 2023 · EHDS

European E-Pharmacy association demands EU-wide online prescription sales

1 Sept 2023
Topic — Revision of the general pharmaceutical legislation to modernize access to medicines across Europe.
Message — The association urges the EU to permit online sales of prescription medicines across member states. They also request removing marketing restrictions and clarifying rules for electronic patient leaflets.12
Why — These changes would remove barriers to market expansion and reduce administrative marketing burdens.34
Impact — Traditional pharmacies may lose market share and face stricter enforcement regarding delivery regulations.5
Read full response

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

14 Jul 2023 · Directive on Medicinal products for human use

European e-pharmacies seek exemptions from strict packaging rules

21 Apr 2023
Topic — The EU plans to regulate packaging design and waste to boost recycling.
Message — They request exemptions from space limits to maintain medicine safety standards. Mandatory reuse quotas must be based on proven carbon footprint reductions.12
Why — This prevents administrative burdens and preserves specific shipping safety requirements.34
Impact — Environmental groups lose progress if shipping sectors are granted packaging exemptions.5
Read full response

Meeting with Sara Cerdas (Member of the European Parliament, Shadow rapporteur) and Bundesärztekammer and Doctolib

7 Dec 2022 · Espaço Europeu de Dados de Saúde

Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur) and European Pain Federation EFIC

22 Nov 2022 · European Health Data Space - EHDS

European e-pharmacies urge creation of central EU medication database

27 Jul 2022
Topic — The initiative aims to create a secure European Health Data Space for medical data sharing.
Message — They request mandatory interoperability standards and a single EU medication database for online pharmacies. They also push for a European Digital Identity and harmonized cross-border reimbursement for telehealth.123
Why — Access to health data allows online pharmacies to compete equally with established local providers.4
Impact — Restrictive national health systems and local pharmacies lose their exclusive control over medicine dispensing.5
Read full response

Meeting with Sandra Gallina (Director-General Health and Food Safety)

28 Apr 2022 ·  EU Pharmaceutical Strategy  Falsified Medicines Directive

Response to Fight against counterfeiting

1 Mar 2022

The EAEP, which represents the voice of leading e-pharmacies on the European continent, welcomes the opportunity to provide feedback on the initiative “EU toolbox against counterfeiting”. We look forward to continuing to engage in this and other policy initiatives stemming from the European Commission's Intellectual Property Action Plan. (Document in attachment)
Read full response

Response to Evaluation and revision of the general pharmaceutical legislation

27 Apr 2021

The European Association of E-Pharmacies (EAEP) would like to submit initial remarks on the evaluation and revision of the general pharmaceutical legislation. As outlined in the combined evaluation roadmap and Inception Impact Assessment, the revision of the general pharmaceutical legal framework aims to ensure access to affordable medicines in the EU. It aims to foster innovation including in areas of unmet medical needs and to enhance security of supply while adapting to new scientific and technological developments and reducing regulatory burden where possible. Drawing lessons from the COVID-19 pandemic, it will support a future-proof and crisis-resistant pharmaceuticals system. For more details please refer to the attached document.
Read full response

Response to Europe’s digital decade: 2030 digital targets

5 Mar 2021

The European Association of E-Pharmacies (EAEP), formerly “EAMSP”, welcomes the opportunity to contribute to the forthcoming Communication on the ´Europe’s digital decade: 2030 digital targets´. As e-Pharmacies, we are experienced digital players which have digital transformation on top of our minds in our daily business to ensure that our customers and patients are empowered to live healthy lives. It is our vision that Europe becomes the digital global leader which has the capacity and technological capabilities to act independently and autonomously, providing optimal conditions for its citizens to health(care), wellbeing, safety and security the “European way”. Please refer to the attached document for details.
Read full response

Response to Digital Services Act: deepening the Internal Market and clarifying responsibilities for digital services

19 Feb 2021

Dear Sir or Madam, Herewith we send you the detailed position of the European Association of E-Pharmacies (EAEP, formerly EAMSP) on the Digital Service Act (DSA). Kind regards Sebastian Schulz
Read full response

Response to A European Health Data Space

2 Feb 2021

Dear Sir or Madam, In the attachment I am sending you the position of the European Association of E-Pharmacies (formerly EAMSP) on the creation of a European Health Data Space. Please do not hesitate to contact us if you have any comments or questions. Kind regards Sebastian Schulz Secretary EAEP
Read full response

Meeting with Shane Sutherland (Cabinet of Commissioner Phil Hogan)

6 Sept 2016 · Annual Reception